The ChronosAntibiotics Project aims to re-sensitise resistant bacteria to antibiotics.
It is an example of an ERC consolidator grant awarded to and co-ordinated by The New University of Lisbon over a 5 year period. With antibiotic resistant bacteria set to kill around 300 million people over the next 35 years an alternative strategy to find antimicrobial therapies remains a global challenge. The ChronosAntibiotic project will use Staphylococcus aureus (the most common multi-drug resistant bacterium in the EU) to help carry out its experiments. The project proposes to accelerate antibiotic discovery having already developed powerful biological tools to study cell division and synthesis of the cell surface in the lab.